Struggling with Opioid Use?
Bradenton Research Center is currently seeking adults who are using Buprenorphine or Suboxone but are still struggling with opioid use for a clinical trial evaluating a new GLP-1 medication. Our focus is on providing effective Opioid Use Disorder treatment options.
Opioid Use Disorder is a serious public health issue affecting millions across the United States. Understanding the complexities of addiction can help in developing effective treatment strategies. Factors such as genetics, environment, and mental health contribute to an individual’s risk of developing OUD. Addressing these factors holistically is crucial for effective recovery.
What is Opioid Use Disorder?
Research shows that individuals with OUD often struggle with co-occurring mental health disorders, such as depression and anxiety. These conditions can complicate recovery efforts and require integrated treatment approaches. Our study is designed to provide comprehensive support that takes these co-occurring issues into account.
Learn more about the OUD study
The GLP-1 medication being evaluated in our study is hypothesized to work by modulating appetite and cravings, which may be especially beneficial for those who find traditional treatment methods insufficient. By participating in this clinical trial, individuals have a chance to be at the forefront of research that could redefine OUD treatment.
Join Our Study!
Qualified participants may receive:
Study-related medical evaluations and care
New GLP-1 Investigational study medication
Study-related procedures and assessments
Compensation for time and travel
There is no cost to participate in the clinical trial, and insurance is typically not required for study-related care.
Participation in studies is voluntary, and all medical attention, care, and treatment are provided at no cost.
Contact us today
This study also emphasizes the importance of community support during recovery. Participants will have access to group sessions where they can share experiences and strategies with others facing similar challenges, fostering a sense of belonging and understanding.
Opioid Use Disorder Clinical Trial
- Participants must:
- Be 18 years of age or older
- Currently prescribed Buprenorphine or Suboxone
- Still actively using opioids despite current treatment
- Motivated to stop using opioids and participate in a clinical trial
Advantages of Participating
In addition to medical evaluations, participants will benefit from lifestyle coaching, which can enhance their chances of maintaining long-term recovery. Coaches will help individuals set and achieve personal goals related to health, wellness, and daily living.
As part of the trial, participants will also receive educational resources to deepen their understanding of OUD, including its effects on the brain and body, helping to destigmatize the condition and empower individuals in their recovery journey.
Participants in this clinical research study may have the opportunity to:
Access a new GLP-1 investigational medication that is not yet widely available.
Receive regular medical evaluations and monitoring from an experienced clinical research team.
Learn more about their OUD and overall health through study-related assessments.
Help researchers evaluate an exciting new potential treatment option.
Contribute to medical knowledge that could help people with Opioid Use Disorder in the future.
Access to a new research medicine
A medical expert will provide close attention and supervision
Opportunity to advance potential new treatments
Reimbursement for travel and time
Participate in a study today!
Taking part in this clinical trial means not only contributing to personal health but also to the broader understanding of OUD. Participants become advocates for change, potentially influencing future treatments and policies that impact the lives of many.
Let us answer your questions about this exciting new study.
Contact us today.
Address
3924 9th Ave W, Bradenton, FL 34205
Call Us
(941) 708-0005
Email Us
info@bradentonresearch.com